Next Article in Journal
Effect of Meadowsweet Flower Extract-Pullulan Coatings on Rhizopus Rot Development and Postharvest Quality of Cold-Stored Red Peppers
Next Article in Special Issue
Peptides Derived from Rhopilema esculentum Hydrolysate Exhibit Angiotensin Converting Enzyme (ACE) Inhibitory and Antioxidant Abilities
Previous Article in Journal
GA3 and Other Signal Regulators (MeJA and IAA) Improve Xanthumin Biosynthesis in Different Manners in Xanthium strumarium L.
Previous Article in Special Issue
Cyclodepsipeptides: A Rich Source of Biologically Active Compounds for Drug Research
Article Menu

Export Article

Open AccessArticle
Molecules 2014, 19(9), 12909-12924;

Effects of Egg Yolk-Derived Peptide on Osteogenic Gene Expression and MAPK Activation

Department of Food & Biotechnology, Hanseo University, Seosan, Chungnam 356-706, Korea
College of Korean Medicine, Semyung University, Chungbuk 390-711, Korea
These authors contributed equally to this work.
Author to whom correspondence should be addressed.
Received: 16 June 2014 / Revised: 7 August 2014 / Accepted: 12 August 2014 / Published: 25 August 2014
(This article belongs to the Special Issue Peptide Chemistry)
Full-Text   |   PDF [2578 KB, uploaded 25 August 2014]   |  


The present study investigated the effects of egg yolk-derived peptide (YPEP) on osteogenic activities and MAPK-regulation of osteogenic gene expressions. The effects of YPEP on cell proliferation, alkaline phosphatase activity, collagen synthesis, and mineralization were measured in human osteoblastic MG-63 cells. Activation of MAPKs and downstream transcription factors such as extracellular-signal-regulated kinase 1/2 (ERK1/2), c-Jun N-terminal kinase 1/2 (JNK1/2), p38, ELK1, and cJUN were examined using western blot analysis. YPEP dose-dependently increased MG-63 cell proliferation, ALP activity, collagen synthesis, and calcium deposition. YPEP activated ERK1/2, p38, and ELK1 phosphorylation whereas JNK and cJUN were not affected by YPEP. The COL1A1 (collagen, type I, alpha 1), ALPL (alkaline phosphatase), and SPP1 (secreted phosphoprotein 1, osteopontin) gene expressions were increased while BGLAP (osteocalcin) was not affected by YPEP. The ERK1/2 inhibitor (PD98509) blocked the YPEP-induced COL1A1 and ALPL gene expressions as well as ELK1 phosphorylation. The p38 inhibitor (SB203580) blocked YPEP-induced COL1A1 and ALPL gene expressions. SPP1 gene expression was not affected by these MAPK inhibitors. In conclusion, YPEP treatment stimulates the osteogenic differentiation via the MAPK/ELK1 signaling pathway. These results could provide a mechanistic explanation for the bone-strengthening effects of YPEP. View Full-Text
Keywords: egg yolk peptide; osteogenic gene; MAPK; MG-63 cell egg yolk peptide; osteogenic gene; MAPK; MG-63 cell

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Kim, H.K.; Kim, M.-G.; Leem, K.-H. Effects of Egg Yolk-Derived Peptide on Osteogenic Gene Expression and MAPK Activation. Molecules 2014, 19, 12909-12924.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top